Overview

RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial)

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The RESTORE trial will determine whether resveratrol supplementation can improve walking performance in older people with lower extremity peripheral arterial disease (PAD). Resveratrol, a polyphenol and natural supplement, specifically targets several impairments associated with walking difficulty and mobility loss in people with PAD.
Phase:
N/A
Details
Lead Sponsor:
Northwestern University
Collaborator:
National Institute on Aging (NIA)
Treatments:
Resveratrol